<DOC>
	<DOCNO>NCT00084253</DOCNO>
	<brief_summary>The purpose study find 300 mg ATV plus 100 mg ritonavir ( RTV ) work well 400 mg ATV alone part regimen stavudine XR lamivudine slow stop progression HIV infection patient never use anti-HIV drug .</brief_summary>
	<brief_title>Study Boosted Atazanavir ( ATV ) Versus Non-boosted ATV Naive Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Signed Informed Consent HIV RNA great equal 200 copies/mL screen 18 year old old Must use barrier contraception Women childbearing potential must negative serum urine pregnancy test within 72 hour begin take study medication Unable unwilling use acceptable method birth control entire study period include 8 week study Women use oral contraceptive , pregnant breastfeed woman Women positive pregnancy test enrollment begin take study medication People life expectancy great 12 month Newly diagnose HIVrelated OI medical condition require acute therapy time enrollment Any antiretroviral therapy within 30 day prior screen Any prior antiretroviral therapy ( great 30 day NRTI and/or great 7 day nonnucleoside reversetranscriptase inhibitor ( NNRTI ) protease inhibitor therapy ) Any following condition : Cushings Syndrome , Gilbert 's Syndrome , untreated hypothyroidism hyperthyroidism , suspect primary ( acute ) HIV infection , obstructive liver disease , proven suspect acute hepatitis 30 day prior study entry , Intractable diarrhea ( great 6 loose stool per day least 78 consecutive day ) within 30 day prior study entry , history hemophilia , history acute chronic pancreatitis , presence cardiomyopathy ( due cause ) significant cardiovascular disease , unstable ischemic heart disease Active alcohol substance abuse History sign symptoms bilateral peripheral neuropathy great grade 2 time screen Previous therapy myelosuppressive , neurotoxic , pancreatotoxic , hepatotoxic , cytotoxic potential within 3 month study start expect need therapy therapy methadone ribavirin/interferons treatment neurotoxic drug drug affect CYP3A4 Inability swallow capsule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>HIV</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>